EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Immune checkpoint molecules and spatial transcriptome profiles according to BRAF status in acral melanoma

Hee Joo Yang iD, Myoung Eun Choi iD, Do Hyung Kim iD, Chong Hyun Won, Sung Eun Chang, Mi Woo Lee, Woo Jin Lee

Journal of the European Academy of Dermatology and Venereology · 2025

DOI: 10.1111/jdv.20780 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of the European Academy of Dermatology and Venereology, 2025. Verfasst von Hee Joo Yang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Dermatology, Dongguk University Ilsan Hospital, Dongguk University College of Medicine, Dongguk University, Goyang, Korea. Hauptthemen laut MEDLINE: Melanoma, Proto-Oncogene Proteins B-raf, Skin Neoplasms, Transcriptome. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Research Foundation of Korea, Asan Institute for Life Sciences, Asan Medical Center.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Acral melanoma (AM) shows different genomic profiles based on BRAF status, and the data on the association with BRAF and immune checkpoint molecules are lacking.

Objectives

This study aimed to identify the significance of BRAF mutation in AMs, exploring expression patterns of immune checkpoint molecules and transcriptome profiles related to tumour immunity according to BRAF status.

Methods

Immunohistochemical (IHC) staining of BRAF, Programmed death‐1 (PD‐1), Lymphocyte‐activation gene‐3 (LAG‐3) and T‐Cell Immunoglobulin and mucin domain‐3 (TIM‐3) was performed on AM tissues. Through spatial transcriptome analysis, the correlation between BRAF expression and immune checkpoint molecule expression was examined. Analysis on differentially expressed genes along with pathway analysis and immune cell deconvolution was performed comparing BRAF‐high and BRAF‐low groups at the mRNA level.

Results

In IHC and spatial transcriptome analysis, BRAF positivity was associated with high expression of PD‐1, LAG‐3 and TIM‐3. Among a total of 144 patients, positive IHC results for BRAF ( p < 0.01), PD‐1 ( p < 0.01), LAG‐3 ( p < 0.01) and TIM‐3 ( p < 0.01) were significantly associated with histopathologic traits including pathological subtypes, cytomorphology, pagetoid spread and nest formation. In spatial transcriptome analysis, the expression level of LAG‐3 showed a significant association with the expression level of BRAF ( p < 0.01). Pathways related to anti‐tumour immunity were significantly downregulated in the BRAF‐high group. In immune cell deconvolution, endothelial cells ( p = 0.001), mast cells ( p = 0.014) and neutrophils ( p = 0.004) were significantly higher in the BRAF‐high group.

Conclusions

BRAF mutation in AM is associated with increased expression of immune checkpoint molecules, supporting the use of immunotherapy for BRAF‐mutant AM in clinical practice. Different tumour microenvironments regarding tumour immunity in BRAF‐mutant AM may explain the poor prognosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MelanomaProto-Oncogene Proteins B-rafSkin NeoplasmsTranscriptomeImmune Checkpoint ProteinsHumansFemaleMaleMiddle AgedHepatitis A Virus Cellular Receptor 2AgedProgrammed Cell Death 1 ReceptorMutationLymphocyte Activation Gene 3 ProteinAdultAntigens, CDGene Expression ProfilingAged, 80 and over

Substanzen

Proto-Oncogene Proteins B-rafBRAF protein, humanHAVCR2 protein, humanHepatitis A Virus Cellular Receptor 2Programmed Cell Death 1 ReceptorPDCD1 protein, humanLymphocyte Activation Gene 3 ProteinLag3 protein, humanAntigens, CDImmune Checkpoint Proteins

Autor:innen und Institutionen

  • Dermatology, Dongguk University Ilsan Hospital, Dongguk University College of Medicine, Dongguk University, Goyang, Korea.
  • Department of Dermatology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.

ORCID-Profile: Hee Joo Yang, Myoung Eun Choi, Do Hyung Kim

Förderung

  • National Research Foundation of Korea
  • Asan Institute for Life Sciences, Asan Medical Center

Zitieren

APA

Yang, H. J., Choi, M. E., Kim, D. H., Won, C. H., Chang, S. E., Lee, M. W., & Lee, W. J. (2025). Immune checkpoint molecules and spatial transcriptome profiles according to BRAF status in acral melanoma. Journal of the European Academy of Dermatology and Venereology. https://doi.org/10.1111/jdv.20780

Vancouver

Yang HJ, Choi ME, Kim DH, Won CH, Chang SE, Lee MW, et al. Immune checkpoint molecules and spatial transcriptome profiles according to BRAF status in acral melanoma. Journal of the European Academy of Dermatology and Venereology. 2025. doi:10.1111/jdv.20780

BibTeX
@article{Yang2025,
  author = {Yang, Hee Joo and Choi, Myoung Eun and Kim, Do Hyung and Won, Chong Hyun and Chang, Sung Eun and Lee, Mi Woo and Lee, Woo Jin},
  title = {Immune checkpoint molecules and spatial transcriptome profiles according to BRAF status in acral melanoma},
  journal = {Journal of the European Academy of Dermatology and Venereology},
  year = {2025},
  doi = {10.1111/jdv.20780}
}
Kostenlos starten →